Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • CDK
    (1)
  • Nrf2
    (1)
  • YAP
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
Filter
Search Result
Results for "

anti-tumoral activity

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Recombinant Protein
    4
    TargetMol | Recombinant_Protein
  • BI-1347
    T54052163056-91-3
    BI-1347 is a potent, selective inhibitor of CDK8/cyclinC (IC50: 1 nM). It shows tumor growth inhibition in an in vivo xenograft model.
    • $34
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • CV-4-26
    T200708
    CV-4-26 (Compound 22) acts as a covalent inhibitor of TEAD. By inhibiting YAP/TEAD-driven transcription, it diminishes the expression of CTGF and CYR61. Furthermore, CV-4-26 impedes colony formation in Huh7 and HepG2 cells, inducing cell cycle arrest and apoptosis (apoptosis). This compound demonstrates anti-tumoral activity against hepatocellular carcinoma (HCC) and hepatoblastoma (HB).
    • Inquiry Price
    Inquiry
    Size
    QTY
  • Keap1-Nrf2-IN-21
    T89558
    Keap1-Nrf2-IN-21 (compound 4d) acts as an inhibitor of glucose metabolism with anti-tumoral properties. It targets the glycolytic pathway by affecting the Keap1-Nrf2 signaling pathway, which in turn suppresses glycolytic activity in cancer cells and inhibits tumor growth. Additionally, Keap1-Nrf2-IN-21 exhibits cytotoxic effects on the HEC1A cell line with an IC50 value of 2.60 μM.
    • Inquiry Price
    Inquiry
    Size
    QTY